Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China flag China · Delayed Price · Currency is CNY
4.230
-0.040 (-0.94%)
Jun 12, 2025, 2:45 PM CST

SHE:002424 Revenue

Guizhou Bailing Group Pharmaceutical had revenue of 760.59M CNY in the quarter ending March 31, 2025, a decrease of -42.93%. This brings the company's revenue in the last twelve months to 3.25B, down -27.77% year-over-year. In the year 2024, Guizhou Bailing Group Pharmaceutical had annual revenue of 3.83B, down -10.26%.

Revenue (ttm)
3.25B
Revenue Growth
-27.77%
P/S Ratio
1.79
Revenue / Employee
493.96K
Employees
6,582
Market Cap
5.83B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.83B-437.59M-10.26%
Dec 31, 20234.26B722.84M20.42%
Jan 1, 20233.54B429.01M13.79%
Jan 1, 20223.11B23.24M0.75%
Dec 31, 20203.09B237.30M8.32%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition